3 Questions with Dr. Erika Moore
Feb. 22, 2023
The Lupus Research Alliance has funded some of the biggest breakthroughs in lupus research, and we’re pleased...
Stories & News
LRA Joins NIAMS Coalition in Supporting Congressional Act Promoting Clinical Trial Diversity
The Lupus Research Alliance and Lupus Therapeutics support diversity in clinical trials to ensure that populations that test potential...
Recognizing a Lupus Research Hero: Kaamilah Gilyard
February 3, 2023
This month, we celebrate lupus warrior Kaamilah Gilyard who is determined to change the lives of future...
Join Kerry Harrington – Run Upcoming NYC Half-Marathon to Support Lupus Research
January 27, 2023
At 23, Kerry Harrington is running the NYC Half Marathon with LRA’s Team Life Without Lupus for...
2022 LRA Advocacy a Success for Lupus Research
January 6, 2023
With the help of our advocates throughout the year, 2022 was a year of great action and...
New Year’s Message from LRA President & CEO Albert Roy
NEW YEAR'S MESSAGE FROM
LRA PRESIDENT & CEOAs we welcome in the new year, hear from Lupus Research Alliance President...
LRA-Funded Researchers Presented Cutting Edge Methods and Discoveries at the Annual Rheumatology Meeting
November, 2022
The Lupus Research Alliance (LRA) aims to support the best science to prevent, treat and cure lupus.
This year...
Make a Difference for Lupus Research in 60 Seconds!
November 10, 2022
As you probably know, the LRA and our advocates were highly instrumental in creating the Department of...
Lupus Wins Big at Dedicated NY Jets Game
November 2, 2022
Last Sunday brought major fundraising support to the Lupus Research Alliance (LRA) during Lupus Awareness Day at the...
Jets and Lupus Research Alliance to Host Lupus Awareness Day on Sunday
October 26, 2022
The New York Jets and Lupus Research Alliance will host Lupus Awareness Day on October 30, 2022,...
From Struggling to Walk to Running NYC TCS Marathon!
October 18, 2022
Ten years ago, Megan Rosa struggled to walk because of her lupus – now she’s training for...
Lupkynis® (voclosporin) Granted Marketing Authorization in the European Union for Lupus Nephritis
September 21, 2022
Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults...